Dextropropoxyphene (International)
Scheme
Prop.INN
ATC (Anatomical Therapeutic Chemical Classification)
N02AC04
CAS registry number (Chemical Abstracts Service)
0000469-62-5
Chemical Formula
C22-H29-N-O2
Molecular Weight
339
Therapeutic Categories
Opioid analgesic
Opioid receptor agonist
Chemical Names
(1S,2R)-1-Benzyl-3-dimetylamino-2-metyl-1-phenylpropyl propionate (BAN)
4-Dimetylamino-1,2-diphenyl-3-metyl-2-propionoxybutane (WHO)
Foreign Names
- Dextropropoxyphenum (Latin)
- Dextropropoxyphen (German)
- Dextropropoxyphène (French)
- Dextropropoxifeno (Spanish)
Generic Names
- Destropropoxifene (OS: DCIT)
- Dextropropoxyphene (OS: BAN)
- Propoxyphène (OS: DCF)
- L 16298 (IS)
- α-$Id$R-propoxyphene (IS)
- UNII-S2F83W92TK (IS)
- Dextropropoxyphene Hydrochloride (OS: BANM)
- Propoxyphene Hydrochloride (OS: USAN)
- SK 65 (IS)
- UNII-CB2TL9PS0T (IS)
- Dextropropoxyphène (chlorhydrate de) (PH: Ph. Eur. 9)
- Dextropropoxyphene Hydrochloride (PH: BP 2018)
- Dextropropoxyphene hydrochloride (PH: Ph. Eur. 9)
- Dextropropoxyphenhydrochlorid (PH: Ph. Eur. 9)
- Dextropropoxypheni hydrochloridum (PH: Ph. Eur. 9)
- Propoxyphene Hydrochloride (PH: USP 35)
- Dextropropoxyphene Napsilate (OS: BANM)
- Propoxyphene Napsylate (OS: USAN)
- Dextropropoxyphene 2-naphtalenesulfonate (IS)
- Dextropropoxyphene Napsylate (IS)
- S-9700 (IS)
- UNII-38M219L1OJ (IS)
- Dextropropoxyphene Napsilate (PH: BP 2018)
- Propoxyphene Napsylate (PH: USP 35)
Brand Names
- Acrogesico
Acromax, Ecuador - Algaphan [+ Paracetamol]
Efroze, Pakistan - Darvocet [+ Paracetamol]
Ranbaxy, India - Dextrodip [+ Metamizole]
Drawer, Argentina - Dianagesic [+ Paracetamol]
Helicon, Pakistan - Dibagesic
Diba, Mexico - Distalgesic [+ Paracetamol]
Dista, Egypt - Femldol [+ Chlorpheniramine]
Pacific, Pakistan - Klosidol [+ Metamizole]
Bago, Argentina - Lafegesic [+ Ibuprofen]
Lafedar, Argentina - Lupivon [+ Paracetamol]
Lupin, India - Sudhinol [+ Paracetamol]
Ranbaxy, India - Algaphan [+ Paracetamol]
Efroze, Kenya - Analphene [+ Paracetamol]
Lisko, Pakistan - Corbutyl [+ Paracetamol]
Sanofi Aventis, India - Dacoton
Standard, Taiwan - Darvin [+ Paracetamol]
Pharmedic, Pakistan - Darwocit [+ Paracetamol]
Wilshire, Pakistan - Depain X [+Paracetamol]
Panion & BF, Taiwan - Deprogesic [+ Paracetamol]
Popular, Pakistan - Dextasgesic [+ Paracetamol]
Eros, Pakistan - Diagesic [+ Paracetamol]
Wilshire, Pakistan - Dipirona + Dextropropoxifeno Larjan [+ Metamizole]
Larjan, Uruguay - Distalgesic [+ Paracetamol]
Eli Lilly, Pakistan - Dolpocetmol [+ Paracetamol]
Synco, Hong Kong - Draphene [+ Paracetamol]
Lisko, Pakistan - Dypon [+ Paracetamol]
Donvalley, Pakistan - Jalgesic [+ Paracetamol]
Irza, Pakistan - Medonol [+ Paracetamol]
Medochemie, Hong Kong - Neo-Percodan [+ Paracetamol]
Sanofi-Aventis, Mexico - Panat [+ Metamizole]
FU, Uruguay - Propoxyphene Hydrochlorie NBCD
NBCD/ DOH, Taiwan - Proxyvon [+ Paracetamol]
Wockhardt, India - Qual [+ Paracetamol, + Diazepam]
Silanes, Mexico - Romidon
Stragen Nordic, Greece - Saludex
Salus, Mexico - Tong-Well [+ Paracetamol]
Royal, Taiwan - U-comphen [+ Paracetamol]
U-Liang, Taiwan - Wygesic [+ Paracetamol]
Wyeth, India - Da Ning [+ Paracetamol]
HengRui Medicine, China - Klosidol [+ Metamizole]
Bago, Paraguay; Bagó, Ecuador - Lifron [+ Metamizol]
Life, Ecuador - Proxyvon [+ Paracetamol]
Wockhardt, India - Spasmo-Proxyvon [+ Dicycloverine, + Paracetamol]
Wockhardt, India - Tong Li Tuo [+ Paracetamol]
Shenyang First Pharmaceutical Factory, China - Vicefeno [+ Metamizole]
Fabra, Argentina
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.